Package 71332-002-01

Brand: tavalisse

Generic: fostamatinib
NDC Package

Package Facts

Identity

Package NDC 71332-002-01
Digits Only 7133200201
Product NDC 71332-002
Product ID 71332-002_78828503-b88f-4e3d-9add-8b738c4cf28e
Description

60 TABLET in 1 BOTTLE (71332-002-01)

Marketing

Marketing Status
Marketed Since 2018-05-09
Brand tavalisse
Generic fostamatinib
Sample Package No

Linked Drug Pages (1)

TAVALISSE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "78828503-b88f-4e3d-9add-8b738c4cf28e", "openfda": {"unii": ["SQ8A3S5101"], "rxcui": ["2044922", "2044928", "2044930", "2044932"], "spl_set_id": ["21149cc3-049b-43e2-b141-c9499160556c"], "manufacturer_name": ["Rigel Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71332-002-01)", "package_ndc": "71332-002-01", "marketing_start_date": "20180509"}], "brand_name": "TAVALISSE", "product_id": "71332-002_78828503-b88f-4e3d-9add-8b738c4cf28e", "dosage_form": "TABLET", "product_ndc": "71332-002", "generic_name": "FOSTAMATINIB", "labeler_name": "Rigel Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TAVALISSE", "active_ingredients": [{"name": "FOSTAMATINIB", "strength": "150 mg/1"}], "application_number": "NDA209299", "marketing_category": "NDA", "marketing_start_date": "20180509", "listing_expiration_date": "20261231"}